GoBear is now part of Finder
Picture not described

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Vaxart (VXRT) shares

Learn how to easily invest in Vaxart shares.

Vaxart Inc is a biotechnology business based in the US. Vaxart shares (VXRT) are listed on the NASDAQ and all prices are listed in US Dollars. Vaxart employs 28 staff and has a trailing 12-month revenue of around USD$1.2 million.

How to buy shares in Vaxart

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – VXRT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Compare online brokers

Name Product Number of Stocks Shares Available Markets
Interactive Brokers
Access to global markets
Yes
Global markets
Your capital is at risk.
Saxo Markets
19,000+
Yes
Global markets
Your capital is at risk.
Plus500
2,000+
No
US, UK, AU, DE, FR, IT, PT, GR, JP, SG, ZA, NL, FI, BE, DK, SE, CH, ES, AT, NO, HU, CZ, IE, PL, HK
CFD Service. Your capital is at risk.
BlackBull Markets
N/A
No
UK, HK, JP, MY, NZ, US
CFD Service. Your capital is at risk.
Libertex
50+
No
Worldwide with exception.
Except for: US/Australia/New Zealand/Belgium/British Virgin Islands/Guam/Lebanon/United States Minor/Outlying Islands/Northern Mariana Islands/Uganda/Philippines/Sri Lanka/Kuwait/South Africa/Azerbaijan/Canada/Armenia/Russia/Japan/Brasil.
CFD Service. Your capital is at risk.
Exness
N/A
No
CH, VN, TH, PH, SG, ID, IN, UAE, ZA, SA, EG, BR, CR, MX
CFD Service. Your capital is at risk.
IG
17,000+
No
DK, IE, NO, RU, DE, IT, AT, CH, ES, LU, PT, SE, FR, NL, RO, UK, US, AU, JP, SG, ZA, AE
CFD Service. Your capital is at risk.
loading

Compare up to 4 providers

How has Coronavirus impacted Vaxart's stock price?

Since the stock market crash in March caused by coronavirus, Vaxart's stock price has had significant positive movement.

Its last market close was $6.88, which is 84.16% up on its pre-crash value of $1.09 and 607.96% up on the lowest point reached during the March crash when the stocks fell as low as $0.9718.

If you had bought $1,000 worth of Vaxart stocks at the start of February 2020, those stocks would have been worth $1,156.25 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $4,300.00.

Is it a good time to buy Vaxart stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Vaxart shares at a glance

Information last updated 2021-10-16.
Latest market close$6.88
52-week range$3.71 - $15.80
50-day moving average $8.03
200-day moving average $7.55
Wall St. target price$12.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.48

Vaxart stock price (NASDAQ: VXRT)

Use our graph to track the performance of VXRT stocks over time.

Vaxart price performance over time

Historical closes compared with the close of $6.88 from 2021-10-21

1 week (2021-10-14) -4.44%
1 month (2021-09-20) -12.58%
3 months (2021-07-22) -17.11%
6 months (2021-04-22) 19.44%
1 year (2020-10-22) 26.24%
2 years (2019-10-22) 1,866.28%
3 years (2018-10-22) 119.11%
5 years (2016-10-21) 355.63%

Vaxart financials

Revenue TTM $1.2 million
Gross profit TTM $-15,817,000
Return on assets TTM -22.69%
Return on equity TTM -45.05%
Profit margin 0%
Book value $1.63
Market capitalisation $869.4 million

TTM: trailing 12 months

Shorting Vaxart shares

There are currently 18.9 million Vaxart shares held short by investors – that's known as Vaxart's "short interest". This figure is 16.1% up from 16.2 million last month.

There are a few different ways that this level of interest in shorting Vaxart shares can be evaluated.

Vaxart's "short interest ratio" (SIR)

Vaxart's "short interest ratio" (SIR) is the quantity of Vaxart shares currently shorted divided by the average quantity of Vaxart shares traded daily (recently around 3.0 million). Vaxart's SIR currently stands at 6.35. In other words for every 100,000 Vaxart shares traded daily on the market, roughly 6350 shares are currently held short.

However Vaxart's short interest can also be evaluated against the total number of Vaxart shares, or, against the total number of tradable Vaxart shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Vaxart's short interest could be expressed as 0.15% of the outstanding shares (for every 100,000 Vaxart shares in existence, roughly 150 shares are currently held short) or 0.1547% of the tradable shares (for every 100,000 tradable Vaxart shares, roughly 155 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Vaxart.

Vaxart share dividends

We're not expecting Vaxart to pay a dividend over the next 12 months.

Have Vaxart's shares ever split?

Vaxart's shares were split on a 1:11 basis on 13 February 2018. So if you had owned 11 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Vaxart shares – just the quantity. However, indirectly, the new 1000% higher share price could have impacted the market appetite for Vaxart shares which in turn could have impacted Vaxart's share price.

Vaxart share price volatility

Over the last 12 months, Vaxart's shares have ranged in value from as little as $3.71 up to $15.8. A popular way to gauge a stock's volatility is its "beta".

VXRT.US volatility(beta: 0.51)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vaxart's is 0.5134. This would suggest that Vaxart's shares are less volatile than average (for this exchange).

Vaxart overview

Vaxart, Inc. , a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI. 1 and GII. 4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which completed Phase I clinical trial for the treatment of SARS-CoV-2 infection. It is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus. Vaxart, Inc.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask Finder

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy Policy and Terms.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site